Akebia Therapeutics
AKBA
#7494
Rank
A$0.61 B
Marketcap
A$2.32
Share price
-3.14%
Change (1 day)
-25.97%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: A$0.61 Billion

As of December 2025 Akebia Therapeutics has a market cap of A$0.61 Billion. This makes Akebia Therapeutics the world's 7494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.61 B-10.05%
2024A$0.68 B99.49%
2023A$0.34 B119.82%
2022A$0.15 B-71.4%
2021A$0.54 B3.63%
2020A$0.52 B-52.08%
2019A$1.09 B19.7%
2018A$0.91 B1.91%
2017A$0.90 B62.67%
2016A$0.55 B1.78%
2015A$0.54 B87.69%
2014A$0.28 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Akebia Therapeutics was reported to be:

A$0.61 Billion
by Nasdaq info icon info icon
A$0.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$267.43 B 43,368.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$381.77 B 61,952.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
A$732.43 B 118,948.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$1.74 B 183.22%๐Ÿ‡บ๐Ÿ‡ธ USA